Circulation. 2003;108:257-260
Published online before print July 14, 2003, doi: 10.1161/01.CIR.0000083366.33686.11
Published online before print July 14, 2003, doi: 10.1161/01.CIR.0000083366.33686.11
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2003;108:257.)
© 2003 American Heart Association, Inc.
Brief Rapid Communications |
Coronary Restenosis After Sirolimus-Eluting Stent Implantation
Morphological Description and Mechanistic Analysis From a Consecutive Series of Cases
From Erasmus Medical Center, Thoraxcenter, Rotterdam, the Netherlands.
Correspondence to Prof P.W. Serruys, MD, PhD, Thoraxcenter, Bd-406, Dr Molewaterplein 40, 3015-GD Rotterdam, The Netherlands. E-mail p.w.j.c.serruys{at}erasmusmc.nl
Received March 25, 2003; de novo received May 2, 2003; revision received June 3, 2003; accepted June 5, 2003.
Background— We describe the clinical and morphological patterns of restenosis after sirolimus-eluting stent (SES) implantation.
Methods and Results— From 121 patients with coronary angiography obtained >30 days after SES implantation, restenosis (diameter stenosis >50%) was identified in 19 patients and 20 lesions (located at the proximal 5-mm segment in 30% or within the stent in 70%). Residual dissection after the procedure or balloon trauma outside the stent was identified in 83% of the proximal edge lesions. Lesions within the stent were focal, and stent discontinuity was identified in some lesions evaluated by intravascular ultrasound.
Conclusions— Sirolimus-eluting stent edge restenosis is frequently associated with local trauma outside the stent. In-stent restenosis occurs as a localized lesion, commonly associated with a discontinuity in stent coverage. Local conditions instead of intrinsic drug-resistance to sirolimus are likely to play a major role in post-SES restenosis.
Key Words: restenosis • stents • angioplasty
Related Article:
Circulation 2003 108: 248-249.
This article has been cited by other articles:
 |
|
 |
|
  X. Liu, H. Doi, A. Maehara, G. S. Mintz, J. de Ribamar Costa Jr, K. Sano, G. Weisz, G. D. Dangas, A. J. Lansky, E. M. Kreps, et al. A Volumetric Intravascular Ultrasound Comparison of Early Drug-Eluting Stent Thrombosis Versus Restenosis J. Am. Coll. Cardiol. Intv., May 1, 2009; 2(5): 428 - 434. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Qiangjun Cai, K. Skelding, A. Armstrong Jr, D. Desai, G. C. Wood, and J. Blankenship Predictors of Long-Term Major Adverse Cardiac Events and Clinical Restenosis Following Elective Percutaneous Coronary Stenting Angiology, April 1, 2009; 60(2): 141 - 147. [Abstract] [PDF]
|
|
|
|
 |
|
 H. B. Lim, G. Hur, S. Y. Kim, Y. H. Kim, S. U. Kwon, W. R. Lee, and S. J. Cha Coronary Stent Fracture: Detection with 64-Section Multidetector CT Angiography in Patients and in Vitro Radiology, December 1, 2008; 249(3): 810 - 819. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. O. Jensen, M. Maeng, P. Thayssen, E. H. Christiansen, K. N. Hansen, A. Galloe, H. Kelbaek, J. F. Lassen, and L. Thuesen Neointimal hyperplasia after sirolimus-eluting and paclitaxel-eluting stent implantation in diabetic patients: The Randomized Diabetes and Drug-Eluting Stent (DiabeDES) Intravascular Ultrasound Trial Eur. Heart J., November 2, 2008; 29(22): 2733 - 2741. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. M.M. van Beusekom, F. Saia, J. D. Zindler, P. A. Lemos, S. L. S.-t. Hoor, M. A.H. van Leeuwen, P. J. de Feijter, P. W. Serruys, and W. J. van der Giessen Drug-eluting stents show delayed healing: paclitaxel more pronounced than sirolimus Eur. Heart J., April 12, 2007; (2007) ehm064v1. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. J. Corbett, J. Cosgrave, G. Melzi, R. Babic, G. G.L. Biondi-Zoccai, C. Godino, N. Morici, F. Airoldi, I. Michev, M. Montorfano, et al. Patterns of restenosis after drug-eluting stent implantation: insights from a contemporary and comparative analysis of sirolimus- and paclitaxel-eluting stents Eur. Heart J., October 1, 2006; 27(19): 2330 - 2337. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. S. Mintz and N. J. Weissman Intravascular Ultrasound in the Drug-Eluting Stent Era J. Am. Coll. Cardiol., August 1, 2006; 48(3): 421 - 429. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Pugliese, F. Cademartiri, C. van Mieghem, W. B. Meijboom, P. Malagutti, N. R. A. Mollet, C. Martinoli, P. J. de Feyter, and G. P. Krestin Multidetector CT for visualization of coronary stents. RadioGraphics, May 1, 2006; 26(3): 887 - 904. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. G. Raja Drug-Eluting Stents and the Future of Coronary Artery Bypass Surgery: Facts and Fiction Ann. Thorac. Surg., March 1, 2006; 81(3): 1162 - 1171. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Alfonso Residual coronary dissections after drug-eluting stenting: the good, the bad, and the ugly Eur. Heart J., March 1, 2006; 27(5): 503 - 505. [Full Text] [PDF]
|
|
|
|
 |
|
 P. C.N. Rensen, K. W. van Dijk, and L. M. Havekes Apolipoprotein AV: Low Concentration, High Impact Arterioscler Thromb Vasc Biol, December 1, 2005; 25(12): 2445 - 2447. [Full Text] [PDF]
|
|
|
|
 |
|
 E Iofina, P W Radke, P Skurzewski, P K Haager, R Blindt, K-C Koch, P Hanrath, J vom Dahl, and R Hoffmann Superiority of sirolimus eluting stent compared with intracoronary {beta} radiation for treatment of in-stent restenosis: a matched comparison Heart, December 1, 2005; 91(12): 1584 - 1589. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Thiele, S. Oettel, S. Jacobs, R. Hambrecht, P. Sick, J. F. Gummert, F. W. Mohr, G. Schuler, and V. Falk Comparison of Bare-Metal Stenting With Minimally Invasive Bypass Surgery for Stenosis of the Left Anterior Descending Coronary Artery: A 5-Year Follow-Up Circulation, November 29, 2005; 112(22): 3445 - 3450. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A E Rodriguez, M Rodriguez Alemparte, C F Vigo, C Fernandez Pereira, C Llaurado, D Vetcher, A Pocovi, and J Ambrose Role of oral rapamycin to prevent restenosis in patients with de novo lesions undergoing coronary stenting: results of the Argentina single centre study (ORAR trial) Heart, November 1, 2005; 91(11): 1433 - 1437. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K.-B. Seung, Y.-H. Kim, D.-W. Park, B.-K. Lee, C. W. Lee, M.-K. Hong, P.-J. Kim, W.-S. Chung, S.-J. Tahk, S.-W. Park, et al. Effectiveness of Sirolimus-Eluting Stent Implantation for the Treatment of Ostial Left Anterior Descending Artery Stenosis With Intravascular Ultrasound Guidance J. Am. Coll. Cardiol., September 6, 2005; 46(5): 787 - 792. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. E. Sousa, M. A. Costa, A. Abizaid, F. Feres, A. C. Seixas, L. F. Tanajura, L. A. Mattos, R. Falotico, J. Jaeger, J. J. Popma, et al. Four-Year Angiographic and Intravascular Ultrasound Follow-Up of Patients Treated With Sirolimus-Eluting Stents Circulation, May 10, 2005; 111(18): 2326 - 2329. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Costa and D. I. Simon Molecular Basis of Restenosis and Drug-Eluting Stents Circulation, May 3, 2005; 111(17): 2257 - 2273. [Full Text] [PDF]
|
|
|
|
|
|
D. J. Drenth, F. Zijlstra, P. W. Boonstra, N. Sawhney, P. S. Teirstein, J. W. Moses, M. B. Leon, R. E. Kuntz, J. J. Popma, W. Bachinsky, et al. Letter Regarding Article by Sawhney et al, "Treatment of Left Anterior Descending Coronary Artery Disease With Sirolimus-Eluting Stents" * Response Circulation, April 26, 2005; 111(16): e265 - e266. [Full Text] [PDF]
|
|
|
|
 |
|
 M. Andrassy, D. Belov, E. Harja, Y. S. Zou, M. Leitges, H. A. Katus, P. P. Nawroth, S. D. Yan, A. M. Schmidt, and S.-F. Yan Central Role of PKC{beta} in Neointimal Expansion Triggered by Acute Arterial Injury Circ. Res., March 4, 2005; 96(4): 476 - 483. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Iakovou, T. Schmidt, L. Ge, G. M. Sangiorgi, G. Stankovic, F. Airoldi, A. Chieffo, M. Montorfano, M. Carlino, I. Michev, et al. Angiographic patterns of restenosis after paclitaxel-eluting stent implantation J. Am. Coll. Cardiol., March 1, 2005; 45(5): 805 - 806. [Full Text] [PDF]
|
|
|
|
|
|
T. Fukui, S. Takanashi, and Y. Hosoda Coronary Endarterectomy and Stent Removal in Patients With In-Stent Restenosis Ann. Thorac. Surg., February 1, 2005; 79(2): 558 - 563. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. C H John Cardiac revascularization--a need for independent decision-makers J R Soc Med, January 1, 2005; 98(1): 1 - 2. [Full Text] [PDF]
|
|
|
|
|
|
H. Takebayashi, G. S. Mintz, S. G. Carlier, Y. Kobayashi, K. Fujii, T. Yasuda, R. A. Costa, I. Moussa, G. D. Dangas, R. Mehran, et al. Nonuniform Strut Distribution Correlates With More Neointimal Hyperplasia After Sirolimus-Eluting Stent Implantation Circulation, November 30, 2004; 110(22): 3430 - 3434. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. A. Lemos, N. Mercado, R. T. van Domburg, R. E. Kuntz, W. W. O'Neill, and P. W. Serruys Comparison of Late Luminal Loss Response Pattern After Sirolimus-Eluting Stent Implantation or Conventional Stenting Circulation, November 16, 2004; 110(20): 3199 - 3205. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. J. Murphy, A. J. Bryan, and G. D. Angelini Hybrid Coronary Revascularization in the Era of Drug-Eluting Stents Ann. Thorac. Surg., November 1, 2004; 78(5): 1861 - 1867. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F Saia, P A Lemos, C A Arampatzis, A Hoye, M Degertekin, K Tanabe, G Sianos, P C Smits, W J van der Giessen, P J de Feyter, et al. Routine sirolimus eluting stent implantation for unselected in-stent restenosis: insights from the rapamycin eluting stent evaluated at Rotterdam cardiology hospital (RESEARCH) registry Heart, October 1, 2004; 90(10): 1183 - 1188. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G W Mikhail, F Airoldi, D Tavano, A Chieffo, R Rogacka, M Carlino, M Montorfano, G Sangiorgi, N Corvaja, I Michev, et al. The use of drug eluting stents in single and multivessel disease: results from a single centre experience Heart, September 1, 2004; 90(9): 990 - 994. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A Halkin, S Carlier, and M B Leon Late incomplete lesion coverage following Cypher stent deployment for diffuse right coronary artery stenosis Heart, August 1, 2004; 90(8): e45 - e45. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Naka, L. G. Bucciarelli, T. Wendt, L. K. Lee, L. L. Rong, R. Ramasamy, S. F. Yan, and A. M. Schmidt RAGE Axis: Animal Models and Novel Insights Into the Vascular Complications of Diabetes Arterioscler Thromb Vasc Biol, August 1, 2004; 24(8): 1342 - 1349. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. A. Lemos, C. A.G. van Mieghem, C. A. Arampatzis, A. Hoye, A. T.L. Ong, E. McFadden, G. Sianos, W. J. van der Giessen, P. J. de Feyter, R. T. van Domburg, et al. Post-Sirolimus-Eluting Stent Restenosis Treated With Repeat Percutaneous Intervention: Late Angiographic and Clinical Outcomes Circulation, June 1, 2004; 109(21): 2500 - 2502. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. R. Holmes Jr How Many Grails Do We Need? Circulation, May 11, 2004; 109(18): 2158 - 2159. [Full Text] [PDF]
|
|
|
|
 |
|
 S.-F. Yan, R. Ramasamy, L. G Bucciarelli, T. Wendt, L. K Lee, B. I Hudson, D. M Stenr, E. Lalla, S. Du Yan, L. L. Rong, et al. RAGE and its ligands: a lasting memory in diabetic complications? Diabetes and Vascular Disease Research, May 1, 2004; 1(1): 10 - 20. [Abstract] [PDF]
|
|
|
|
 |
|
 P. H Chong and J. W. Cheng Early Experiences and Clinical Implications of Restenosis and Drug-Eluting Stents: Part 2 Ann. Pharmacother., May 1, 2004; 38(5): 845 - 852. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Orford, A. Lerman, and D. R. Holmes Routine intravascular ultrasound guidance of percutaneous coronary intervention: A critical reappraisal J. Am. Coll. Cardiol., April 21, 2004; 43(8): 1335 - 1342. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. J. Drenth, N. J.G.M. Veeger, J. G. Grandjean, M. A. Mariani, A. J. van Boven, and P. W. Boonstra Isolated high-grade lesion of the proximal LAD: a stent or off-pump LIMA? Eur. J. Cardiothorac. Surg., April 1, 2004; 25(4): 567 - 571. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. A. Lemos, A. Hoye, D. Goedhart, C. A. Arampatzis, F. Saia, W. J. van der Giessen, E. McFadden, G. Sianos, P. C. Smits, S. H. Hofma, et al. Clinical, Angiographic, and Procedural Predictors of Angiographic Restenosis After Sirolimus-Eluting Stent Implantation in Complex Patients: An Evaluation From the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) Study Circulation, March 23, 2004; 109(11): 1366 - 1370. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. J. McKenna Drug-Eluting Stent Restenosis Rates? Circulation, March 9, 2004; 109 (9): e154 - e154. [Full Text] [PDF]
|
|
|
|
|
|
K. Fujii, G. S. Mintz, Y. Kobayashi, S. G. Carlier, H. Takebayashi, T. Yasuda, I. Moussa, G. Dangas, R. Mehran, A. J. Lansky, et al. Contribution of Stent Underexpansion to Recurrence After Sirolimus-Eluting Stent Implantation for In-Stent Restenosis Circulation, March 9, 2004; 109(9): 1085 - 1088. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. W. O'Neill and S. R. Dixon The year in interventional cardiology J. Am. Coll. Cardiol., March 3, 2004; 43(5): 875 - 890. [Full Text] [PDF]
|
|
|
|
|
|
P. A. Lemos, P. W. Serruys, R. T. van Domburg, F. Saia, C. A. Arampatzis, A. Hoye, M. Degertekin, K. Tanabe, J. Daemen, T. K.K. Liu, et al. Unrestricted Utilization of Sirolimus-Eluting Stents Compared With Conventional Bare Stent Implantation in the "Real World": The Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) Registry Circulation, January 20, 2004; 109(2): 190 - 195. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. R. Marks Sirolimus for the Prevention of In-Stent Restenosis in a Coronary Artery N. Engl. J. Med., October 2, 2003; 349(14): 1307 - 1309. [Full Text] [PDF]
|
|
|
|
|
|
S. B. King III Restenosis: The Mouse That Roared Circulation, July 22, 2003; 108(3): 248 - 249. [Full Text] [PDF]
|
|